Precipitating factors of migraine attacks in patients attended in neurology services. The FACTOR study

被引:7
|
作者
Mateos, Valentin [1 ]
Guerrero-Peral, Angel L. [2 ]
Garcia, Margarida [3 ]
Armengol-Bertolin, Silvia [4 ]
Jose Plazas, M. [4 ]
机构
[1] Ctr Med Asturias, Area Neurol, E-33193 Oviedo, Asturias, Spain
[2] Hosp Clin Univ, Valladolid, Spain
[3] Adknoma Hlth Res, Barcelona, Spain
[4] Dept Med Almirall, Barcelona, Spain
关键词
Disability; Headaches; Migraine; Pain; Precipitating factors; Stress; TENSION-TYPE HEADACHE; TRIGGER FACTORS; UNITED-STATES; POPULATION; PREVALENCE; AURA; DISABILITY; DIAGNOSIS; PATTERNS; SPAIN;
D O I
10.33588/rn.5411.2012185
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Introduction. Patients with migraine often report factors or circumstances that precipitate or trigger their attacks. Yet few studies have been conducted to examine this matter. Aim. To explore the factors that precipitate migraine in our setting, as well is their possible relation with the intensity of the attacks or the overall repercussion of migraine. Patients and methods. An epidemiological, cross-sectional, multi-centre study was conducted in neurology consultation services. Sociodemographic and clinical data were collected and the precipitating factors were identified from a closed list. The specific migraine disability questionnaire -Headache Impact Test (HIT-6)- and the measurement of the number of lost workday equivalents were used in the study. Results. Altogether 817 patients were recruited (72.5% females, mean age: 34.6 +/- 10.3 years). A total of 70.5% of the patients had severe disability according to the HIT-6. The mean monthly number of lost workday equivalents was 2.1 +/- 2.5. A total of 96.6% of the patients identified some precipitating factor for the attacks, the most commonly reported being hormonal (75.2%), stress (70.9%) and those related with disorders affecting sleep patterns (68.4%). Conclusions. The FACTOR study confirms that most patients with migraine identify some circumstance that precipitates their attacks. Controlling or avoiding these factors, whenever possible, must be part of the programme of education received by patients suffering from migraine.
引用
收藏
页码:641 / 648
页数:8
相关论文
共 50 条
  • [41] Treatment with sumatriptan 50 mg in the mildphase of migraine attacks in patients withinfrequent attacks: A randomised, double-blind,placebo-controlled study
    Tfelt-Hansen P.
    Bach F.W.
    Daugaard D.
    Tsiropoulos I.
    Riddersholm B.
    The Journal of Headache and Pain, 2006, 7 (6) : 389 - 394
  • [42] The MIGREX study: Prevalence and risk factors of sexual dysfunction among migraine patients
    Torres-Ferrus, M.
    Lopez-Veloso, A. C.
    Gonzalez-Quintanilla, V.
    Gonzalez-Garcia, N.
    de Teran, J. Diaz
    Gago-Veiga, A.
    Camina, J.
    Ruiz, M.
    Mas-Sala, N.
    Bohorquez, S.
    Gallardo, V. J.
    Pozo-Rosich, P.
    NEUROLOGIA, 2023, 38 (08): : 541 - 549
  • [43] The Effect of Propofol Anesthesia on the Pain Severity and Frequency of Migraine Attacks in Patients with Chronic Migraine Headache over a Six Month Follow Up: An Observational Study
    Vosoughian, Maryam
    Saeedi, Nima
    Moshari, Mohammadreza
    Dabir, Shideh
    Dahi, Mastaneh
    Tabashi, Soudeh
    Tehrani, Khadijeh Haji Naghi
    Hajizadeh, Nastaran
    IRANIAN JOURNAL OF PHARMACEUTICAL RESEARCH, 2021, 20 (04): : 415 - 421
  • [44] Precipitating factors of diabetic ketoacidosis in type 1 diabetes patients at a tertiary hospital: a cross-sectional study with a two-time-period comparison
    da Rosa Carlos Monteiro, Laura Emanuelle
    Garcia, Sheila Piccoli
    Bottino, Leonardo Grabinski
    Custodio, Julia Luchese
    Telo, Gabriela Heiden
    Schaan, Beatriz D.
    ARCHIVES OF ENDOCRINOLOGY METABOLISM, 2022, 66 (03): : 355 - 361
  • [45] Treatment with sumatriptan 50 mg in the mild phase of migraine attacks in patients with infrequent attacks. A randomized, double-blind, placebo-controlled study
    Tfelt-Hansen, P
    Bach, F
    Daugaard, D
    Tsiropoulos, I
    Riddersholm, B
    CEPHALALGIA, 2005, 25 (10) : 932 - 932
  • [46] Predisposing and Precipitating Factors for Delirium in the Very Old (≥80 Years): A Prospective Cohort Study of 3,076 Patients
    Marquetand, Justus
    Bode, Leonie
    Fuchs, Simon
    Ernst, Jutta
    von Kaenel, Roland
    Boettger, Sonke
    GERONTOLOGY, 2021, 67 (05) : 599 - 607
  • [47] Precipitating factors of porphyria cutanea tarda in Brazil with emphasis on hemochromatosis gene (HFE) mutations. Study of 60 patients
    Jorge Vieira, Fatima Mendonca
    Nakhle, Maria Cristina
    Abrantes-Lemos, Clarice Pires
    Rachid Cancado, Eduardo Luiz
    Silva dos Reis, Vitor Manoel
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2013, 88 (04) : 530 - 540
  • [48] Post-abortion contraceptive utilization and associated factors among women who attended abortion services: A health facility cross-sectional study
    Shiferaw, Birhanu Melaku
    Kokeb, Lealm Netsanet
    Bantie, Getasew Mulat
    Workie, Hailemariam Mekonnen
    SAGE OPEN MEDICINE, 2024, 12
  • [49] Risk of recurrent venous thromboembolism in patients with the factor V Leiden (FVR506Q) mutation: effect of warfarin and prediction by precipitating factors
    Baglin, C
    Brown, K
    Luddington, R
    Baglin, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 100 (04) : 764 - 768
  • [50] INTRAVENOUS MAGNESIUM-SULFATE RELIEVES MIGRAINE ATTACKS IN PATIENTS WITH LOW SERUM IONIZED MAGNESIUM LEVELS - A PILOT-STUDY
    MAUSKOP, A
    ALTURA, BT
    CRACCO, RQ
    ALTURA, BM
    CLINICAL SCIENCE, 1995, 89 (06) : 633 - 636